Search results
Here's Why You Should Invest in Beam Therapeutics (BEAM) Now
Zacks via Yahoo News· 3 weeks agoBeam Therapeutics Inc. BEAM is evaluating its leading ex-vivo genome-editing candidate, BEAM-101, in...
Vertex (VRTX) Rises 16.5% YTD: Time to Bet On the Stock?
Zacks via Yahoo News· 1 month agoVertex Pharmaceuticals Incorporated VRTX has been witnessing strong revenue growth, regulatory...
Editas (EDIT) Reports Upbeat New Data From Reni-Cel Studies
Zacks via Yahoo News· 1 month agoEditas (EDIT) reports positive new safety and efficacy data from the RUBY and EdiTHAL studies...
Geron (GERN) Wins FDA Approval for Blood Cancer Drug, Stock Up
Zacks via Yahoo News· 2 months agoGeron's (GERN) shares rise on approval of its first drug. The FDA approves imetelstat for the...
Agios (AGIO) Up 21% on Upbeat Data From 2nd Thalassemia Study
Zacks via Yahoo News· 2 months agoData from a late-stage study shows that transfusion-dependent thalassemia patients who received...
Top Stock Reports for UnitedHealth, Danaher & Abbott
Zacks via Yahoo News· 2 months agoToday's Research Daily features new research reports on 16 major stocks, including UnitedHealth Group Incorporated (UNH), Danaher Corporation (DHR) and...
CRISPR's (CRSP) Q1 Loss Narrower-Than-Expected, Sales Miss
Zacks via Yahoo News· 3 months agoCRISPR Therapeutics (CRSP) reports mixed earnings results for first-quarter 2024. Management claims...
Vertex's (VRTX) Q1 Earnings Beat, Trikafta Drives Sales
Zacks via Yahoo News· 3 months agoVertex's (VRTX) first-quarter earnings and revenues surpass estimates. Higher sales of...
CRISPR (CRSP) to Report Q1 Earnings: What's in the Cards?
Zacks via Yahoo News· 3 months agoOn CRISPR Therapeutics' (CRSP) first-quarter 2024 earnings call, investors' focus is likely to be on...
Agios (AGIO) Q1 Earnings Surpass, Sales Miss Estimates
Zacks via Yahoo News· 3 months agoAgios (AGIO) reports mixed earnings results for first-quarter 2024. Though sales miss the mark,...